MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,939K
Free Cash flow
-$651K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from issuance of common...
Accrued expenses and other curre...
Accounts payable
Others
Negative Cash Flow Breakdown
Accounts receivable, net
Prepaid expenses and other curre...
Net loss
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-330
-581
-819
-534
Depreciation
32
33
34
36
Stock-based compensation
58
135
24
39
Deferred tax asset
-
-
-
-141
Deferred income tax expense
0
431
-107
-
Operating lease right-of-use asset
-40
-38
161
-56
Accounts receivable, net
650
168
-340
78
Inventories, net
81
-19
40
-208
Prepaid expenses and other current assets
364
86
392
15
Deferred consideration, net of discount
24
61
62
59
Accounts payable
216
282
229
-666
Accrued expenses and other current liabilities
391
148
78
158
Withholding tax payable
63
99
109
110
Operating lease liabilities
-40
-39
162
-56
Deferred revenue
-8
-29
-449
0
Net cash used in operating activities
-649
-519
-764
-635
Purchases of property and equipment
2
29
47
10
Net cash used in investing activities
-2
-29
-47
-10
Proceeds from issuance of common stock, net of offering expenses
3,536
161
266
0
Proceeds from exercise of employee stock options
0
0
0
21
Payments for fractional shares related to reverse-split
-
0
0
0
Principal payments on short-term debt
82
51
56
83
Insurance premiums financed
-
277
-
-
Net cash provided by (used in) financing activities
3,454
387
210
-62
Effect of exchange rate on cash and cash equivalents
136
-1
127
137
Net increase (decrease) in cash and cash equivalents
2,939
-162
-474
-570
Cash and cash equivalents, beginning of period
2,399
3,035
3,035
5,374
Cash and cash equivalents, end of period
5,338
2,399
2,561
3,035
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from issuance of
common stock, net of...
$3,536K
Net cash provided by
(used in) financing...
$3,454K
(6055.17%↑ Y/Y)
Effect of exchange rate
on cash and cash...
$136K
(-66.83%↓ Y/Y)
Canceled cashflow
$82K
Net increase
(decrease) in cash and cash...
$2,939K
(266.14%↑ Y/Y)
Canceled cashflow
$651K
Principal payments on
short-term debt
$82K
(1.23%↑ Y/Y)
Accrued expenses and
other current...
$391K
(180.79%↑ Y/Y)
Accounts payable
$216K
(-78.95%↓ Y/Y)
Withholding tax payable
$63K
(-39.42%↓ Y/Y)
Stock-based compensation
$58K
(1.75%↑ Y/Y)
Operating lease
right-of-use asset
-$40K
(-108.93%↓ Y/Y)
Depreciation
$32K
(-11.11%↓ Y/Y)
Deferred consideration,
net of discount
$24K
(-56.36%↓ Y/Y)
Net cash used in
operating activities
-$649K
(67.79%↑ Y/Y)
Net cash used in
investing activities
-$2K
(98.11%↑ Y/Y)
Canceled cashflow
$824K
Accounts receivable, net
$650K
(200.93%↑ Y/Y)
Purchases of property and
equipment
$2K
(-98.11%↓ Y/Y)
Prepaid expenses and
other current assets
$364K
(-55.56%↓ Y/Y)
Net loss
-$330K
(73.41%↑ Y/Y)
Inventories, net
$81K
(-87.58%↓ Y/Y)
Operating lease
liabilities
-$40K
(-108.93%↓ Y/Y)
Deferred revenue
-$8K
(-130.77%↓ Y/Y)
Buy us a coffee
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)